COMPANY
Neurogen Biomarking
Timeline
- Trial start —: Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07701161 | Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device | Not listed | Recruiting | Jan 13, 2025 | Mar 20, 2026 (actual) |